ReShape Lifesciences Inc. (OTCMKTS:RSLSD – Get Free Report) shares shot up 2.3% during mid-day trading on Monday . The company traded as high as $5.37 and last traded at $5.37. 6,500 shares were traded during trading, an increase of 377% from the average session volume of 1,362 shares. The stock had previously closed at $5.25.
ReShape Lifesciences Stock Performance
The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.07 and a current ratio of 1.17. The stock has a fifty day simple moving average of $5.37.
ReShape Lifesciences Company Profile
ReShape Lifesciences Inc, a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy.
Featured Stories
- Five stocks we like better than ReShape Lifesciences
- P/E Ratio Calculation: How to Assess Stocks
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Financial Services Stocks Investing
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Profitably Trade Stocks at 52-Week Highs
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for ReShape Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReShape Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.
